Acquisition costs and yen bite into Eisai's profits
This article was originally published in Scrip
Executive Summary
Eisai expects its net profit to fall by 5% to ¥67.0 billion ($747.8 million) this fiscal year. Profits have been hit by a combination of the strong yen, investment losses and amortisation costs related to its acquisition of MGI Pharma.